Contexium

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

Translational Neural Devices (R61/R33 - Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 28 Jan 2027. The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported…

Opportunity overview

Project name
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
National Institutes of Health logo
National Institutes of Health
Donor
National Institutes of Health

Key details

Opportunity start date
Opportunity end date
Project location(s)
United States

Summary

The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical...

Frequently asked questions

What is Translational Neural Devices (R61/R33 - Clinical Trial Optional)?

Translational Neural Devices (R61/R33 - Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 28 Jan 2027. The purpose of this Notice of Funding Opportunity (NOFO) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported…

Who is funding Translational Neural Devices (R61/R33 - Clinical Trial Optional)?

Translational Neural Devices (R61/R33 - Clinical Trial Optional) is funded by National Institutes of Health.

When is the deadline to apply for Translational Neural Devices (R61/R33 - Clinical Trial Optional)?

The application deadline is 28 Jan 2027 00:00 (UTC).

Where will the Translational Neural Devices (R61/R33 - Clinical Trial Optional) project take place?

The project location(s) are: United States.

How can I apply for Translational Neural Devices (R61/R33 - Clinical Trial Optional)?

Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.